Fouad Shawky A, Basyoni Maha M A, Fahmy Reham A, Kobaisi Mohamed H
Department of Internal Medicine, Cairo University, Cairo, Egypt.
Arab J Gastroenterol. 2011 Dec;12(4):194-200. doi: 10.1016/j.ajg.2011.11.005. Epub 2011 Dec 20.
The pathogenic role of Blastocystis hominis is still regarded by some as controversial. Studies have been in progress for years to evaluate the role of blastocystosis in irritable bowel syndrome (IBS) and demonstrated that faecal carriage of B. hominis was frequent in these patients. This study attempted to distinguish different genotypes of B. hominis isolates obtained from patients with IBS and to evaluate their pathogenic potentials.
One hundred subjects (51 patients with IBS and 49 asymptomatic infected subjects) harbouring B. hominis were investigated by a direct smear examination and in vitro culture of stool samples followed by genotyping of B. hominis by PCR using STS primers. Sigmoidoscopy was done in all subjects and biopsies were taken and subjected to histopathologic examination.
Genotyping proved that only four genotypes of B. hominis were identified. In patients with IBS, genotypes III, I, and IV were detected (28, 15 and 14 isolates, respectively). On the other hand, genotypes III, IV, and II were identified in asymptomatic infected individuals (21, 19 and 13 isolates, respectively). The degrees of chronic inflammatory changes in sigmoidoscopic biopsies caused by B. hominis genotypes among IBS patients revealed that severe inflammation was present mainly in patients harboring genotype I isolates (4/15) (26.66%), while genotype III caused severe inflammation only in 9.09%. Genotype II isolates were not detected in IBS cases. Asymptomatic infected individuals harboring genotypes II, III and IV exhibited mild to moderate inflammatory changes. Genotype I isolates were not detected in asymptomatic infected group. The correlation between different B. hominis genotypes and degree of inflammation was statistically insignificant.
Genotype I was the most pathogenic genotype of B. hominis isolates in patients with IBS while genotype II was not detected among those patients. Also, our results suggest the presence of pathogenic and non-pathogenic strains among genotypes III and IV.
人芽囊原虫的致病作用仍被一些人认为存在争议。多年来一直在进行研究以评估芽囊原虫病在肠易激综合征(IBS)中的作用,并表明这些患者中粪便携带人芽囊原虫很常见。本研究试图区分从IBS患者中获得的人芽囊原虫分离株的不同基因型,并评估其致病潜力。
对100名携带人芽囊原虫的受试者(51例IBS患者和49例无症状感染受试者)进行了直接涂片检查和粪便样本的体外培养,随后使用STS引物通过PCR对人芽囊原虫进行基因分型。对所有受试者进行了乙状结肠镜检查,并取活检组织进行组织病理学检查。
基因分型证明仅鉴定出四种人芽囊原虫基因型。在IBS患者中,检测到基因型III、I和IV(分别为28、15和14个分离株)。另一方面,在无症状感染个体中鉴定出基因型III、IV和II(分别为21、19和13个分离株)。IBS患者中由人芽囊原虫基因型引起的乙状结肠镜活检慢性炎症变化程度显示,严重炎症主要存在于携带基因型I分离株的患者中(4/15)(26.66%),而基因型III仅在9.09%的患者中引起严重炎症。在IBS病例中未检测到基因型II分离株。携带基因型II、III和IV的无症状感染个体表现出轻度至中度炎症变化。在无症状感染组中未检测到基因型I分离株。不同人芽囊原虫基因型与炎症程度之间的相关性无统计学意义。
基因型I是人芽囊原虫分离株在IBS患者中最具致病性的基因型,而在这些患者中未检测到基因型II。此外,我们的结果表明在基因型III和IV中存在致病和非致病菌株。